Main content
Sorry, this episode is not currently available

Bayer to Cut 12,000 Jobs

Is the pharma giant's model fatally damaged by its acquisition of Monsanto?

The pharmaceutical giant insists the cuts are not prompted by its acquisition of Monsanto nor by a costly California court case over the Roundup weedkiller. Professor Erik Gordon at the University of Michigan says it's a challenging market for big pharmaceuticals in the US. Plus, Cary Leahey from Decision Economics in New York explains how Wall Street reacted to the deliberations of the US Federal Reserve over future interest rates.

Release date:

7 minutes

Podcast